JUL 04, 2018 2:11 AM PDT

First Drug Approved for The Treatment of Hyperhidrosis

WRITTEN BY: Nouran Amin

Hyperhidrosis is a chronic skin condition that results in the increased production of sweat than needed. A certain amount of sweat is normally produced to regulate body temperature, an excess of sweat becomes unnecessary.

Now, the U.S. Food and Drug Administration (FDA) has approved the first drug developed to reduce excessive sweating. The drug will particularly be effective in one type of hyperhidrosis caused under the armpit, better known as primary axillary hyperhidrosis.

According to the drug manufacturing California-based pharmaceutical company, Dermira Inc, the drug which is now known as Qbrexza and will be available in pharmacies in October 2018.

Affected individuals prescribed Qbrexza will receive it as a drug packed inside a cloth. They will be able to use it to wipe over their skin every day to block the sweat glands from activating and thus no sweat will be released from the treated area.

Roughly 15 million Americans experience some form of excessive sweating, with more than 10 million individuals experiencing excessive underarm perspiration.

Excessive sweating is often associated with social embarrassment and emotional burdens to affected individuals. Such distress due to this skin condition has inspired dermatologists to seek effective treatment options.

“From the start, our goal was to develop an approach that went beyond masking a person’s excessive underarm sweating and instead focused on treating the condition in a clinically meaningful way," says Derira Chairman Tom Wiggans.

The FDA approval of Qbrexza was based on two clinical trials.

Most frequent noted side effects of Qbrexza include dry mouth, dilated pupils, sore throat, headache, urinary hesitation, blurred vision, dry nose, dry eyes, dry skin and constipation.

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 01, 2020
Cancer
APR 01, 2020
New immunotherapy for ovarian cancer
Research published recently in the Journal of Experimental Medicine suggests that targeting macrophages in a new kind of ...
APR 14, 2020
Cardiology
APR 14, 2020
Personalized Treatments for Patients with Diabetes and Heart Disease
Often, people who have Type 2 diabetes are at an increased risk for cardiovascular disease. This is because they are usu ...
APR 18, 2020
Cancer
APR 18, 2020
A New Double Threat Against Skin Cancer
Skin cancer is one of the most common cancers in America.  One of the most aggressive forms of cancer is melanoma, ...
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
MAY 04, 2020
Cancer
MAY 04, 2020
A Retroactive Study Finds an Immunotherapy Effective as a Third-Line Therapy
Cancer is a particularly persistent disease. Many therapies are composed of one or more different treatments. These trea ...
MAY 06, 2020
Cancer
MAY 06, 2020
Olanzapine useful for cancer patients managing nausea unrelated to chemo
A study published last week in JAMA Oncology reports that a generic drug called Olanzapine could be useful for cancer pa ...
Loading Comments...